Back

Ferric carboxymaltose in heart failure with iron deficiency - the HEART-FID and AFFIRM-AHF trials

12 May 2024 (10:00 - 10:10)
Organised by: Logo
Congress Presentation Part of: Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice? Anaemia/Iron Deficiency Open Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Robert Mentz

Duke University Medical Center, Durham (United States of America)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor T. McDonagh (London, GB) Professor J. Cleland (Glasgow, GB)
Slides
Presentation thumbnail
Ferric derisomaltose in heart failure with iron deficiency - an update from the IRONMAN trial
Professor P. Kalra (Portsmouth, GB)
Slides
Presentation thumbnail
What do the new ESC guidelines recommend
Professor T. McDonagh (London, GB)
Slides
Presentation thumbnail
What's still to come
Professor J. Cleland (Glasgow, GB)
Slides
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 10:00 CET
You may be interested in
thumbnail
Congress Session
IV iron – What is the current status and what are the future perspectives
18 May 2025
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
Trends of phosphorus levels after intravenous administration of ferric carboxymaltose
28 August 2023
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources